Literature DB >> 8747433

Structural effects of the binding of GTP to the wild-type and oncogenic forms of the ras-gene-encoded p21 proteins.

R Monaco1, J M Chen, F K Friedman, P Brandt-Rauf, D Chung, M R Pincus.   

Abstract

Molecular dynamics calculations have been performed to determine the average structures of ras-gene-encoded p21 proteins bound to GTP, i.e., the normal (wild-type) protein and two oncogenic forms of this protein, the Val 12- and Leu 61-p21 proteins. We find that the average structures for all of these proteins exhibit low coordinate fluctuations (which are highest for the normal protein), indicating convergence to specific structures. From previous dynamics calculations of the average structures of these proteins bound to GDP, major regional differences were found among these proteins [Monaco et al. (1995), J. Protein Chem., in press]. We now find that the average structures of the oncogenic proteins are more similar to one another when the proteins are bound to GTP than when they are bound to GDP [Monaco et al. (1995), J. Protein Chem., in press]. However, they still differ in structure at specific amino acid residues rather than in whole regions, in contradistinction to the results found for the p21-GDP complexes. Two exceptions are the regions 25-32, in an alpha-helical region, and 97-110. The two oncogenic (Val 12- and Leu 61-) proteins have similar structures which differ significantly in the region of residues 97-110. This region has recently been identified as being critical in the interaction of p21 with kinase target proteins. The differences in structure between the oncogenic proteins suggest the existence of more than one oncogenic form of the p21 protein that can activate different signaling pathways.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8747433     DOI: 10.1007/bf01886911

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  23 in total

1.  Identification of an intracellular protein that specifically interacts with photoaffinity-labeled oncogenic p21 protein.

Authors:  G Lee; Z A Ronai; M R Pincus; P W Brandt-Rauf; R B Murphy; T M Delohery; S Nishimura; Z Yamaizumi; I B Weinstein
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 2.  ras genes.

Authors:  M Barbacid
Journal:  Annu Rev Biochem       Date:  1987       Impact factor: 23.643

3.  Requirement for Ras in Raf activation is overcome by targeting Raf to the plasma membrane.

Authors:  S J Leevers; H F Paterson; C J Marshall
Journal:  Nature       Date:  1994-06-02       Impact factor: 49.962

4.  Conformational analysis of the 20 naturally occurring amino acid residues using ECEPP.

Authors:  S S Zimmerman; M S Pottle; G Némethy; H A Scheraga
Journal:  Macromolecules       Date:  1977 Jan-Feb       Impact factor: 5.985

5.  Phosphatidylinositol-3-OH kinase as a direct target of Ras.

Authors:  P Rodriguez-Viciana; P H Warne; R Dhand; B Vanhaesebroeck; I Gout; M J Fry; M D Waterfield; J Downward
Journal:  Nature       Date:  1994-08-18       Impact factor: 49.962

6.  Structural significance of the GTP-binding domain of ras p21 studied by site-directed mutagenesis.

Authors:  D J Clanton; Y Y Lu; D G Blair; T Y Shih
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

7.  Human Sos1: a guanine nucleotide exchange factor for Ras that binds to GRB2.

Authors:  P Chardin; J H Camonis; N W Gale; L van Aelst; J Schlessinger; M H Wigler; D Bar-Sagi
Journal:  Science       Date:  1993-05-28       Impact factor: 47.728

8.  Comparison of the computed structures for the phosphate-binding loop of the p21 protein containing the oncogenic site Gly 12 with the X-ray crystallographic structures for this region in the p21 protein and EFtu. A model for the structure of the p21 protein in its oncogenic form.

Authors:  J M Chen; G Lee; R B Murphy; R P Carty; P W Brandt-Rauf; E Friedman; M R Pincus
Journal:  J Biomol Struct Dyn       Date:  1989-04

9.  A peptide from the GAP-binding domain of the ras-p21 protein and azatyrosine block ras-induced maturation of Xenopus oocytes.

Authors:  D L Chung; P Brandt-Rauf; R B Murphy; S Nishimura; Z Yamaizumi; I B Weinstein; M R Pincus
Journal:  Anticancer Res       Date:  1991 Jul-Aug       Impact factor: 2.480

10.  Refined crystal structure of the triphosphate conformation of H-ras p21 at 1.35 A resolution: implications for the mechanism of GTP hydrolysis.

Authors:  E F Pai; U Krengel; G A Petsko; R S Goody; W Kabsch; A Wittinghofer
Journal:  EMBO J       Date:  1990-08       Impact factor: 11.598

View more
  4 in total

1.  Comparison of molecular dynamics averaged structures for complexes of normal and oncogenic ras-p21 with SOS nucleotide exchange protein, containing computed conformations for three crystallographically undefined domains, suggests a potential role of these domains in ras signaling.

Authors:  Thomas Duncan; James M Chen; Fred K Friedman; Mark Hyde; Lyndon Chie; Matthew R Pincus
Journal:  Protein J       Date:  2004-04       Impact factor: 2.371

2.  Computed three-dimensional structures for the ras-binding domain of the raf-p74 protein complexed with ras-p21 and with its suppressor protein, rap-1A.

Authors:  J M Chen; S Manolatos; P W Brandt-Rauf; R B Murphy; R Monaco; M R Pincus
Journal:  J Protein Chem       Date:  1996-08

3.  Conformational effects in the p53 protein of mutations induced during chemical carcinogenesis: molecular dynamic and immunologic analyses.

Authors:  P W Brandt-Rauf; J M Chen; M J Marion; S J Smith; J C Luo; W Carney; M R Pincus
Journal:  J Protein Chem       Date:  1996-05

4.  Novel peptides from the RAS-p21 and p53 proteins for the treatment of cancer.

Authors:  Wilbur B Bowne; Josef Michl; Martin H Bluth; Michael E Zenilman; Matthew R Pincus
Journal:  Cancer Ther       Date:  2007
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.